2025
SJR Q4
JCR Q4 · 0,5
OA
8 matched articles
ESCI
Journal detail
Middle East Journal of Cancer
- Publisher
- Shiraz University of Medical Sciences
- Country
- Iran · Middle East
- Type
- journal
- ISSN
-
2008668720086709
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,192
- Quartile Q4
- H-Index 15
- Cites/doc 0,49
- Docs (3y) 183
- Cites (3y) 89
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 0,5
- 5Y JIF 0,5
- JCI 0,1
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Cancer Research Q4
- Oncology Q4
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q4 | Q4 | 0,192 | 0,5 | 0,5 | 0,1 | Q4 | 15 |
| 2024 | Q4 | Q4 | 0,186 | 0,4 | 0,4 | 0,1 | Q4 | 12 |
| 2023 | Q4 | Q4 | 0,229 | 0,4 | 0,5 | 0,09 | Q4 | 12 |
| 2022 | Q4 | — | 0,172 | 0,4 | 0,5 | 0,06 | Q4 | 12 |
| 2021 | Q4 | — | 0,171 | — | — | 0,09 | Q4 | 12 |
| 2020 | Q4 | — | 0,227 | — | — | 0,11 | Q4 | 12 |
| 2019 | Q4 | — | 0,177 | — | — | — | — | 12 |
| 2017 | Q4 | — | 0,139 | — | — | — | — | 12 |
| 2016 | Q4 | — | 0,129 | — | — | — | — | 12 |
| 2015 | Q4 | — | 0,103 | — | — | — | — | 12 |
| 2014 | — | — | — | — | — | — | — | 12 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | ESCI | Q4 | Q4 | 317/333 |
| 2024 | ONCOLOGY | ESCI | Q4 | Q4 | 313/328 |
| 2023 | ONCOLOGY | ESCI | Q4 | Q4 | 304/322 |
| 2022 | ONCOLOGY | ESCI | — | Q4 | — |
| 2021 | ONCOLOGY | ESCI | — | Q4 | — |
| 2020 | ONCOLOGY | ESCI | — | Q4 | — |